AzTrials
AzTrials

Airway MorbidityNCT04991545

Feasibility of the Infra-Red Illumination for Facilitation of Video Scope-tracheal Intubation

A study testing Application of Infrared (Active IRD/ IRRIS) device in people with Airway Morbidity and Covid19, run by Hamad Medical Corporation at 1 site in Qatar.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Airway securing through the placement of an endotracheal tube continues to be the definitive and the global standard management. The successful first attempt is aimed to avoid the consequences of multiple intubation trials as bleeding, tissue swelling, and airway contamination from gastric content that led to… Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Airway Morbidity, Covid19, Trachea
What is being tested?
Application of Infrared (Active IRD/ IRRIS) device
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteQatar
Study dates
13 Jan 2021to 1 Jan 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Age above 18 years
  • General anesthesia that needs endotracheal intubation
  • All Mallampati score 1-3
  • ASA physical status 1-3

Who cannot join

  • Refuse or unable to sign the consent.
  • Pregnancy
  • Emergency cases
  • History of or expected difficult intubation
  • Maxillofacial abnormality or trauma
  • Age below 18 years
Show all 10Show fewer
  • Rapid sequence induction
  • Skin disorders and skin light sensitivity (SLE, Lupus ….)
  • Impaired head and neck mobility
  • Scars or skin injuries at the neck

Trial locations and contacts

1 site in 1 country.

Nabil Shallik contact

+97444393817

nshallik@hamad.qa

Qatar1 site, 1 recruiting
  • ACC&HGH, Hamad Medical Corporation

    Doha, Doah, 3050

    Nabil Shallik, M.D., 9745543926, nshallik@outlook.com

    Elsayyed Elkarta, M.D.

    Recruiting

Other trials in Qatar

About this study

Official title: Feasibility of the RetrogradeTranscutaneous Infra-Red Illumination for Facilitation of Video Scope-tracheal Intubation

Airway securing through the placement of an endotracheal tube continues to be the definitive and the global standard management. The successful first attempt is aimed to avoid the consequences of multiple intubation trials as bleeding, tissue swelling, and airway contamination from gastric content that led to considerable morbidity and mortality. Visualization of the larynx and the glottic opening is the key to first-pass success requiring long-term training and availability of specific equipment concerned to that. For confirmation of the position endotracheal tube or its displacement, various clinical and equipment aids to that which are not valid or limited in different scenarios. Video laryngoscopes (VL) have been proposed to improve laryngeal visualization, hence a higher first-pass success rate accomplished. Despite that, there are limitations of video laryngoscope use in different circumstances that requiring adding of other aids to facilitate endotracheal intubation.

x

Read the detailed description

Airway securing through the placement of an endotracheal tube continues to be the definitive and the global standard management. The successful first attempt is aimed to avoid the consequences of multiple intubation trials as bleeding, tissue swelling, and airway contamination from gastric content that led to considerable morbidity and mortality. Visualization of the larynx and the glottic opening is the key to first-pass success requiring long-term training and availability of specific equipment concerned to that. For confirmation of the position endotracheal tube or its displacement, various clinical and equipment aids to that which are not valid or limited in different scenarios. Video laryngoscopes (VL) have been proposed to improve laryngeal visualization, hence a higher first-pass success rate accomplished. Despite that, there are limitations of video laryngoscope use in different circumstances that requiring adding of other aids to facilitate endotracheal intubation.

The proposal of this study is to assess the feasibility and the impact of infrared/near-infrared (IRD) light on the performance of video-laryngoscopy and reduction of the time needed for endotracheal intubation and increase the credibility of the device.

Data-collection will be started after induction of the anesthesia and ended at the confirmation of endotracheal tube position

Being tested
Application of Infrared (Active IRD/ IRRIS) device
Keywords
Infra-Red Illumination, Retrograde Transcutaneous, videoscope-tracheal Intubation
Medical subject headings
COVID-19, Tracheal Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Application of Infrared (Active IRD/ IRRIS) deviceDevice

    The first operator experienced with video-laryngoscopy intubation will do Before inducing anesthesia, the second operator will open the randomization envelope and adhere IRRIS/IRD device to the anterior skin of the neck above the sternal notch according to the group of patients After confirming lack of discomfort during application of the IRRIS/IRD device,

    After complete relaxation, Laryngoscopy will be performed by the first operator using video laryngoscope (Glidescope Verathon Medical, BC, Canada or C-Mac Storz, Germany) to insert the tracheal tube. The endotracheal tube will be armed with a malleable stylet and to be molded to a curved 'hockey stick or the same curve of the laryngoscopic blade's shape. We will divide the patient according to device into two groups:

    1. Group A: control group
    2. Group B: Intervention group using Infrared
Study groups in NCT04991545
Study groupRoleWhat they receive
Group A: control group (intubation without IRD/IRRIS device)No interventionGroup A = control group (intubation without IRD/IRRIS device) (15 subjects) The first operator experienced with video-laryngoscopy intubation will do the endotracheal intubation after induction of anesthesia.
Intervention group using Infrared (Active IRD/ IRRIS) deviceExperimentalGroup B = intervention group using Infrared active IRD/IRRIS device (15 subjects) Before inducing anesthesia, the second operator will open the randomization envelope and adhere IRRIS/IRD device to the anterior skin of the neck above the sternal notch according to the group of patients. After confirming lack of discomfort during application of the IRRIS/IRD device, anesthesia will be induced
Receives: Device: Application of Infrared (Active IRD/ IRRIS) device

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. infrared red light on the performance of video-laryngoscopy intubation and its impact on first pass success

    The primary endpoint will be the feasibility of infrared/near-red light on the performance of video-laryngoscopy tracheal intubation and its impact on first pass success

    Measured: During procedure time

Secondary outcomes (7)
  1. Visibility of the glottic entrance

    Visibility of the glottic entrance during intubation

    Measured: During procedure time

  2. Time to recognize the illuminated laryngeal inlet.

    Time to recognize the illuminated laryngeal inlet.

    Measured: one year

  3. Correct intubation

    Recognize the correct intubation pathway by other confirmatory tests

    Measured: one year

  4. Number of intubation attempt.

    Number of intubation attempt by the experience staff.

    Measured: During procedure time

  5. Types of video laryngoscopy

    Types of video laryngoscopy used

    Measured: During procedure time

  6. Alternative techniques of intubation.

    Alternative techniques of intubation if used after failure of primary equipment

    Measured: During procedure time

  7. Safety of Infra Red

    Safety: Presence and severity of skin lesion that might be associated at device application site. (Discomfort, pressure sign, irritation, redness, burn)

    Measured: During procedure time

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Aug 2021
  2. Study start13 Jan 2021
  3. Primary completion1 Jan 2022 (estimated)
  4. Study completion1 Jan 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Factorial
Masking
None (open label)
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04991545
Sponsor's protocol ID
MRC-05-088
Status last verified
Jul 2021
First submitted
28 Jul 2021
Last updated
5 Aug 2021
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: We will share the data after IRB approval

Publications

  • Simpson GD, Ross MJ, McKeown DW, Ray DC. Tracheal intubation in the critically ill: a multi-centre national study of practice and complications. Br J Anaesth. 2012 May;108(5):792-9. doi: 10.1093/bja/aer504. Epub 2012 Feb 6.

    PubMed 22315326
  • Sakles JC, Chiu S, Mosier J, Walker C, Stolz U. The importance of first pass success when performing orotracheal intubation in the emergency department. Acad Emerg Med. 2013 Jan;20(1):71-8. doi: 10.1111/acem.12055.

    PubMed 23574475
  • Webb RK, Currie M, Morgan CA, Williamson JA, Mackay P, Russell WJ, Runciman WB. The Australian Incident Monitoring Study: an analysis of 2000 incident reports. Anaesth Intensive Care. 1993 Oct;21(5):520-8. doi: 10.1177/0310057X9302100507.

    PubMed 8273871
  • Duggan LV, Mastoras G, Bryson GL. Tracheal intubation in patients with COVID-19. CMAJ. 2020 Jun 1;192(22):E607. doi: 10.1503/cmaj.200650. Epub 2020 May 1. No abstract available.

    PubMed 32357995
  • Knapp S, Kofler J, Stoiser B, Thalhammer F, Burgmann H, Posch M, Hofbauer R, Stanzel M, Frass M. The assessment of four different methods to verify tracheal tube placement in the critical care setting. Anesth Analg. 1999 Apr;88(4):766-70. doi: 10.1097/00000539-199904000-00016.

    PubMed 10195521
  • Nemec D, Austin PN, Silvestro LS. Methods to Improve Success With the GlideScope Video Laryngoscope. AANA J. 2015 Dec;83(6):389-97.

    PubMed 26742332
  • Saima S, Asai T, Kimura R, Terada S, Arai T, Okuda Y. [Combined Use of a Videolaryngoscope and a Transilluminating Device for Intubation with Two Difficult Airways]. Masui. 2015 Oct;64(10):1045-7. Japanese.

    PubMed 26742405
  • Kristensen MS, Fried E, Biro P. Infrared Red Intubation System (IRRIS) guided flexile videoscope assisted difficult airway management. Acta Anaesthesiol Scand. 2018 Jan;62(1):19-25. doi: 10.1111/aas.13016. Epub 2017 Oct 24.

    PubMed 29063583
  • Wayne MA, McDonnell M. Comparison of traditional versus video laryngoscopy in out-of-hospital tracheal intubation. Prehosp Emerg Care. 2010 Apr-Jun;14(2):278-82. doi: 10.3109/10903120903537189.

    PubMed 20199237

Questions about this trial

What is this clinical trial studying?

A study testing Application of Infrared (Active IRD/ IRRIS) device in people with Airway Morbidity and Covid19, run by Hamad Medical Corporation at 1 site in Qatar.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 5 Aug 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Qatar. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Nabil Shallik (+97444393817, nshallik@hamad.qa), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

infrared red light on the performance of video-laryngoscopy intubation and its impact on first pass success (time frame: During procedure time). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04991545, which also lists 9 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Aug 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in